Dare Bioscience, Inc. Operating Expenses
Dare Bioscience, Inc. (DARE) reported Operating Expenses of $2.84 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- Dare Bioscience, Inc. operating expenses for the quarter ending 2026-06-30 was $2.84M, a 25.51% decline year-over-year.
- Dare Bioscience, Inc. operating expenses for the quarter ending 2026-03-31 was $2.91M, a 36.85% decline year-over-year.
- Dare Bioscience, Inc. operating expenses for the quarter ending 2025-12-31 was $2.20M, a 58.70% decline year-over-year.
- Dare Bioscience, Inc. operating expenses for the quarter ending 2025-09-30 was $3.67M, a 22.20% decline year-over-year.
- Dare Bioscience, Inc. operating expenses for fiscal 2025 was $14.29M, a 39.11% decline from fiscal 2024.
- Dare Bioscience, Inc. operating expenses for fiscal 2024 was $23.46M, a 30.48% decline from fiscal 2023.
- Dare Bioscience, Inc. operating expenses for fiscal 2023 was $33.75M, a 18.46% decline from fiscal 2022.
- Dare Bioscience, Inc. operating expenses for fiscal 2022 was $41.39M, a 5.93% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 7 month | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed | Operating Expenses 100 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.84M 10-Q · filed 2026-08-13 | $5.74M 10-Q · filed 2026-08-13 | $7.94M derived: sum of 3 quarters · filed 2026-08-13 | $11.62M derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2026-03-31 | $2.91M 10-Q · filed 2026-05-14 | $5.11M derived: sum of 2 quarters · filed 2026-05-14 | $8.78M derived: sum of 3 quarters · filed 2026-05-14 | $12.59M derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2025-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $5.87M derived: sum of 2 quarters · filed 2026-03-26 | $9.68M derived: sum of 3 quarters · filed 2026-08-13 | $14.29M 10-K · filed 2026-03-26 | ||||||
| 2025-09-30 | $3.67M 10-Q · filed 2025-11-13 | $7.48M derived: sum of 2 quarters · filed 2026-08-13 | $12.09M 10-Q · filed 2025-11-13 | $17.41M derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2025-06-30 | $3.81M 10-Q · filed 2026-08-13 | $8.41M 10-Q · filed 2026-08-13 | $13.74M derived: sum of 3 quarters · filed 2026-08-13 | $18.46M derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2025-03-31 | $4.61M 10-Q · filed 2026-05-14 | $9.93M derived: sum of 2 quarters · filed 2026-05-14 | $14.65M derived: sum of 3 quarters · filed 2026-05-14 | $22.04M derived: sum of 4 quarters · filed 2026-05-14 | ||||||
| 2024-12-31 | $5.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $10.05M derived: sum of 2 quarters · filed 2026-03-26 | $17.43M derived: sum of 3 quarters · filed 2026-03-26 | $23.46M 10-K · filed 2026-03-26 | ||||||
| 2024-09-30 | $4.72M 10-Q · filed 2025-11-13 | $12.10M derived: sum of 2 quarters · filed 2025-11-13 | $18.14M 10-Q · filed 2025-11-13 | $25.12M derived: sum of 4 quarters · filed 2025-11-13 | ||||||
| 2024-06-30 | $7.38M 10-Q · filed 2025-08-14 | $13.41M 10-Q · filed 2025-08-14 | $20.39M derived: sum of 3 quarters · filed 2025-08-14 | $29.79M derived: sum of 4 quarters · filed 2025-08-14 | ||||||
| 2024-03-31 | $6.03M 10-Q · filed 2025-05-13 | $13.01M derived: sum of 2 quarters · filed 2025-05-13 | $22.41M derived: sum of 3 quarters · filed 2025-05-13 | $31.40M derived: sum of 4 quarters · filed 2025-05-13 | ||||||
| 2023-12-31 | $6.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $16.38M derived: sum of 2 quarters · filed 2025-03-31 | $25.37M derived: sum of 3 quarters · filed 2025-03-31 | $33.75M 10-K · filed 2025-03-31 | ||||||
| 2023-09-30 | $9.40M 10-Q · filed 2024-11-14 | $18.39M derived: sum of 2 quarters · filed 2024-11-14 | $26.77M 10-Q · filed 2024-11-14 | $43.00M derived: sum of 4 quarters · filed 2024-11-14 | ||||||
| 2023-06-30 | $8.99M 10-Q · filed 2024-08-12 | $17.37M 10-Q · filed 2024-08-12 | $33.60M derived: sum of 3 quarters · filed 2024-08-12 | $40.74M derived: sum of 4 quarters · filed 2024-08-12 | ||||||
| 2023-03-31 | $8.38M 10-Q · filed 2024-05-14 | $24.61M derived: sum of 2 quarters · filed 2024-05-14 | $31.75M derived: sum of 3 quarters · filed 2024-05-14 | $41.37M derived: sum of 4 quarters · filed 2024-05-14 | ||||||
| 2022-12-31 | $16.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $23.37M derived: sum of 2 quarters · filed 2024-03-28 | $32.99M derived: sum of 3 quarters · filed 2024-03-28 | $41.39M 10-K · filed 2024-03-28 | ||||||
| 2022-09-30 | $7.14M 10-Q · filed 2023-11-09 | $16.75M derived: sum of 2 quarters · filed 2023-11-09 | $25.15M 10-Q · filed 2023-11-09 | $34.70M derived: sum of 4 quarters · filed 2023-11-09 | ||||||
| 2022-06-30 | $9.62M 10-Q · filed 2023-08-10 | $18.02M 10-Q · filed 2023-08-10 | $27.56M derived: sum of 3 quarters · filed 2023-08-10 | $40.23M derived: sum of 4 quarters · filed 2023-08-10 | ||||||
| 2022-03-31 | $8.40M 10-Q · filed 2023-05-11 | $17.94M derived: sum of 2 quarters · filed 2023-05-11 | $30.61M derived: sum of 3 quarters · filed 2023-05-11 | $39.78M derived: sum of 4 quarters · filed 2023-05-11 | ||||||
| 2021-12-31 | $9.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $22.21M derived: sum of 2 quarters · filed 2023-03-30 | $31.37M derived: sum of 3 quarters · filed 2023-03-30 | $39.07M 10-K · filed 2023-03-30 | ||||||
| 2021-09-30 | $12.67M 10-Q · filed 2022-11-10 | $21.83M derived: sum of 2 quarters · filed 2022-11-10 | $29.53M 10-Q · filed 2022-11-10 | $37.97M derived: sum of 4 quarters · filed 2022-11-10 | ||||||
| 2021-06-30 | $9.16M 10-Q · filed 2022-08-09 | $16.86M 10-Q · filed 2022-08-09 | $25.30M derived: sum of 3 quarters · filed 2022-08-09 | $32.88M derived: sum of 4 quarters · filed 2022-08-09 | ||||||
| 2021-03-31 | $7.69M 10-Q · filed 2022-05-12 | $16.13M derived: sum of 2 quarters · filed 2022-05-12 | $23.72M derived: sum of 3 quarters · filed 2022-05-12 | $30.84M derived: sum of 4 quarters · filed 2022-05-12 | ||||||
| 2020-12-31 | $8.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $16.02M derived: sum of 2 quarters · filed 2022-03-31 | $23.15M derived: sum of 3 quarters · filed 2022-03-31 | $27.40M 10-K · filed 2022-03-31 | ||||||
| 2020-09-30 | $7.58M 10-Q · filed 2021-11-10 | $14.71M derived: sum of 2 quarters · filed 2021-11-10 | $18.96M 10-Q · filed 2021-11-10 | $22.82M derived: sum of 4 quarters · filed 2021-11-10 | ||||||
| 2020-06-30 | $7.13M 10-Q · filed 2021-08-12 | $11.38M 10-Q · filed 2021-08-12 | $15.24M derived: sum of 3 quarters · filed 2021-08-12 | $18.66M derived: sum of 4 quarters · filed 2021-08-12 | ||||||
| 2020-03-31 | $4.25M 10-Q · filed 2021-05-13 | $8.11M derived: sum of 2 quarters · filed 2021-05-13 | $11.53M derived: sum of 3 quarters · filed 2021-05-13 | $15.52M derived: sum of 4 quarters · filed 2021-05-13 | ||||||
| 2019-12-31 | $3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $7.28M derived: sum of 2 quarters · filed 2021-03-30 | $11.26M derived: sum of 3 quarters · filed 2021-03-30 | $14.34M 10-K · filed 2021-03-30 | ||||||
| 2019-09-30 | $3.42M 10-Q · filed 2020-11-12 | $7.40M derived: sum of 2 quarters · filed 2020-11-12 | $10.48M 10-Q · filed 2020-11-12 | $13.44M derived: sum of 4 quarters · filed 2020-11-12 | ||||||
| 2019-06-30 | $3.98M 10-Q · filed 2020-08-12 | $7.07M 10-Q · filed 2020-08-12 | $10.02M derived: sum of 3 quarters · filed 2020-08-12 | $12.65M derived: sum of 4 quarters · filed 2020-08-12 | ||||||
| 2019-03-31 | $3.08M 10-Q · filed 2020-05-14 | $6.04M derived: sum of 2 quarters · filed 2020-05-14 | $8.66M derived: sum of 3 quarters · filed 2020-05-14 | $12.29M derived: sum of 4 quarters · filed 2020-05-14 | ||||||
| 2018-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $5.58M derived: sum of 2 quarters · filed 2020-03-27 | $9.20M derived: sum of 3 quarters · filed 2020-03-27 | $16.88M 10-K · filed 2020-03-27 | ||||||
| 2018-09-30 | $2.62M 10-Q · filed 2019-11-12 | $6.25M derived: sum of 2 quarters · filed 2019-11-12 | $13.92M 10-Q · filed 2019-11-12 | $23.06M derived: sum of 4 quarters · filed 2019-11-12 | ||||||
| 2018-06-30 | $3.62M 10-Q · filed 2019-08-14 | $11.30M 10-Q · filed 2019-08-14 | $20.44M derived: sum of 3 quarters · filed 2019-08-14 | $21.77M derived: sum of 4 quarters · filed 2019-08-14 | ||||||
| 2018-03-31 | $7.68M 10-Q · filed 2019-05-14 | $16.82M derived: sum of 2 quarters · filed 2019-05-14 | $18.15M derived: sum of 3 quarters · filed 2019-05-14 | $18.63M derived: sum of 4 quarters · filed 2019-05-14 | ||||||
| 2017-12-31 | $9.14M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $10.47M derived: sum of 2 quarters · filed 2019-04-01 | $10.95M derived: sum of 3 quarters · filed 2019-04-01 | $11.18M 10-K · filed 2019-04-01 | ||||||
| 2017-09-30 | $1.33M 10-Q · filed 2018-11-13 | $1.81M derived: sum of 2 quarters · filed 2018-11-13 | $2.04M 10-Q · filed 2018-11-13 | $7.32M derived: sum of 4 quarters · filed 2018-11-13 | ||||||
| 2017-06-30 | $479.62K 10-Q · filed 2018-08-13 | $4.67M 10-Q · filed 2017-08-14 | $708.09K 10-Q · filed 2018-08-13 | $11.40M 10-Q · filed 2017-08-14 | $5.98M derived: sum of 3 quarters · filed 2018-08-13 | $5.99M derived: sum of 4 quarters · filed 2018-08-13 | ||||
| 2017-03-31 | $228.46K 10-Q · filed 2018-05-14 | $6.74M 10-Q · filed 2017-05-12 | $5.50M derived: sum of 2 quarters · filed 2018-05-14 | $5.51M derived: sum of 3 quarters · filed 2018-05-14 | $15.80M derived: sum of 4 quarters · filed 2018-05-14 | |||||
| 2016-12-31 | $5.27M 10-K/A · filed 2017-06-13 | $5.28M derived: sum of 2 quarters · filed 2017-11-13 | $15.57M derived: sum of 3 quarters · filed 2017-11-13 | $630.59K 10-K · filed 2018-03-28 | $37.92M 10-K · filed 2017-03-31 | |||||
| 2016-09-30 | $5.96K 10-Q · filed 2017-11-13 | $9.46M 10-Q · filed 2016-11-03 | $10.30M derived: sum of 2 quarters · filed 2017-11-13 | $441.95K 10-Q · filed 2017-11-13 | $32.65M 10-Q · filed 2016-11-03 | $33.22M derived: sum of 4 quarters · filed 2017-11-13 | ||||
| 2016-06-30 | $367.92K 8-K/A · filed 2017-10-02 | $456.05K 8-K/A · filed 2017-10-02 | $23.18M 10-Q · filed 2016-08-04 | $33.21M derived: sum of 3 quarters · filed 2017-08-14 | $43.26M derived: sum of 4 quarters · filed 2017-08-14 | |||||
| 2016-03-31 | $12.89M 10-K/A · filed 2017-06-13 | $22.92M derived: sum of 2 quarters · filed 2017-06-13 | $32.96M derived: sum of 3 quarters · filed 2017-06-13 | $42.36M derived: sum of 4 quarters · filed 2017-06-13 | ||||||
| 2015-12-31 | $10.03M 10-K/A · filed 2017-06-13 | $20.07M derived: sum of 2 quarters · filed 2017-06-13 | $55.15K 8-K/A · filed 2017-10-02 | $29.47M derived: sum of 3 quarters · filed 2017-06-13 | $37.17M 10-K/A · filed 2017-06-13 | |||||
| 2015-09-30 | $10.05M 10-K/A · filed 2017-06-13 | $19.44M derived: sum of 2 quarters · filed 2017-06-13 | $27.14M 10-Q · filed 2016-11-03 | $34.45M derived: sum of 4 quarters · filed 2017-06-13 | ||||||
| 2015-06-30 | $9.39M 10-K/A · filed 2017-06-13 | $17.10M 10-Q · filed 2016-08-04 | $24.41M derived: sum of 3 quarters · filed 2017-06-13 | $29.77M derived: sum of 4 quarters · filed 2017-06-13 | ||||||
| 2015-03-31 | $7.70M 10-K/A · filed 2017-06-13 | $15.01M derived: sum of 2 quarters · filed 2017-06-13 | $20.38M derived: sum of 3 quarters · filed 2017-06-13 | $25.06M derived: sum of 4 quarters · filed 2017-06-13 | ||||||
| 2014-12-31 | $7.31M 10-K · filed 2016-03-10 | $12.68M derived: sum of 2 quarters · filed 2016-03-10 | $17.35M derived: sum of 3 quarters · filed 2016-03-10 | $20.36M 10-K/A · filed 2017-06-13 | ||||||
| 2014-09-30 | $5.37M 10-K · filed 2016-03-10 | $10.05M derived: sum of 2 quarters · filed 2016-03-10 | $13.05M 10-Q · filed 2015-11-16 | $16.07M derived: sum of 4 quarters · filed 2016-03-10 | ||||||
| 2014-06-30 | $4.68M 10-K · filed 2016-03-10 | $7.68M 10-Q · filed 2015-08-06 | $10.70M derived: sum of 3 quarters · filed 2016-03-10 | $13.51M derived: sum of 4 quarters · filed 2016-03-10 | ||||||
| 2014-03-31 | $3.00M 10-K · filed 2016-03-10 | $6.02M derived: sum of 2 quarters · filed 2016-03-10 | $8.83M derived: sum of 3 quarters · filed 2016-03-10 | $13.42M derived: sum of 4 quarters · filed 2016-03-10 | $101.62M 10-Q · filed 2014-05-27 | |||||
| 2013-12-31 | $3.02M 10-K · filed 2015-03-19 | $5.83M derived: sum of 2 quarters · filed 2015-03-19 | $10.41M derived: sum of 3 quarters · filed 2015-03-19 | $15.87M 10-K · filed 2016-03-10 | ||||||
| 2013-09-30 | $2.81M 10-K · filed 2015-03-19 | $7.40M derived: sum of 2 quarters · filed 2015-03-19 | $12.85M 10-Q · filed 2014-11-13 | |||||||
| 2013-06-30 | $4.59M 10-K · filed 2015-03-19 | $10.04M 10-Q · filed 2014-08-12 | ||||||||
| 2013-03-31 | $5.45M 10-K · filed 2015-03-19 | |||||||||
| 2012-12-31 | $22.20M 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |